Huaren Pharmaceutical Co., Ltd. (SHE:300110)

Huaren Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 3, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	3,925	4,161	4,989	5,013	5,675	5,592
Market Cap Growth	-2.92%	-16.59%	-0.47%	-11.67%	1.48%	12.08%
Enterprise Value	4,626	5,705	6,192	6,865	7,116	5,435
Last Close Price	3.32	3.52	4.19	4.19	4.72	4.64
PE Ratio	-	-	26.53	27.73	43.52	59.10
Forward PE	-	41.18	41.18	41.18	41.18	41.18
PS Ratio	3.13	3.08	3.05	3.10	3.64	4.25
PB Ratio	2.75	3.03	1.80	1.93	2.32	2.40
P/TBV Ratio	11.76	15.62	3.21	3.65	4.82	3.07
P/FCF Ratio	15.73	13.98	19.21	28.54	-	-
P/OCF Ratio	13.37	12.91	16.33	23.00	-	-
EV/Sales Ratio	3.68	4.22	3.78	4.24	4.56	4.13
EV/EBITDA Ratio	26.66	23.17	13.15	17.46	19.71	23.58
EV/EBIT Ratio	72.17	43.87	17.95	28.07	31.40	46.42
EV/FCF Ratio	18.54	19.17	23.84	39.08	-	-
Debt / Equity Ratio	0.60	0.93	0.56	0.64	0.75	0.23
Debt / EBITDA Ratio	4.92	5.18	3.32	4.24	5.09	2.33
Debt / FCF Ratio	3.42	4.29	6.02	9.52	-	-
Asset Turnover	0.30	0.32	0.32	0.30	0.35	0.43
Inventory Turnover	2.99	2.71	3.13	3.41	3.00	3.37
Quick Ratio	0.55	0.54	1.58	1.18	1.05	1.15
Current Ratio	0.74	0.77	1.84	1.35	1.20	1.51
Return on Equity (ROE)	-65.96%	-65.84%	7.21%	7.19%	5.62%	4.23%
Return on Assets (ROA)	0.97%	1.89%	4.17%	2.83%	3.13%	2.39%
Return on Invested Capital (ROIC)	2.88%	3.95%	7.10%	5.44%	6.22%	4.32%
Return on Capital Employed (ROCE)	3.50%	6.90%	9.40%	7.80%	7.40%	5.00%
Earnings Yield	-35.91%	-32.88%	3.77%	3.61%	2.30%	1.69%
FCF Yield	6.36%	7.15%	5.21%	3.50%	-10.69%	-1.23%
Dividend Yield	-	-	0.50%	0.50%	0.38%	0.32%
Payout Ratio	-	-	45.81%	49.44%	54.73%	23.74%
Buyback Yield / Dilution	0.08%	-0.01%	-0.04%	0.33%	-0.23%	-1.22%
Total Shareholder Return	0.08%	-0.01%	0.46%	0.83%	0.15%	-0.90%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.